EUVIMEDEUVIMED entdecken
Open Access

Racial and Ethnic Disparities in Testing of Hepatitis C Virus–Exposed Children Across the United States

Rachel L Epstein iD, Anna Kurnellas, Sarah Munroe iD, Megan R Curtis, Breanne Biondi, Elisha M Wachman

Journal of the Pediatric Infectious Diseases Society · 2024

DOI: 10.1093/jpids/piae082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2024. Verfasst von Rachel L Epstein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Healthcare Disparities, Hepatitis C. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIAID NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite rising hepatitis C virus (HCV) prevalence among pregnant individuals in the United States, HCV testing among exposed infants remains low. Although recent guidelines recommend early ribonucleic acid (RNA) testing for HCV-exposed children to help improve testing rates, national studies describing factors associated with HCV testing and the type of testing completed are lacking.

Methods

In this retrospective national study, we characterized HCV testing and care among HCV-exposed infants born between 2010 and 2020 captured in the electronic health record-based TriNetX Research Network. We analyzed factors associated with appropriate HCV testing completion (negative or positive HCV RNA testing or negative HCV antibody testing at any age through study end in 2022) and with RNA compared with antibody testing using univariable and multivariable logistic regression with clustered standard errors by healthcare organization.

Results

Of 8516 HCV-exposed children, 45.8% completed any HCV testing and 42.1% completed appropriate testing (25% of whom had RNA testing only). A total of 182 (5.1% of appropriately tested children) had evidence of HCV infection. Of 104 treatment-eligible children, 14.4% were treated. Black (odds ratio [OR]: 0.38, 95% confidence interval [CI]: 0.26–0.55), Asian/Pacific Islander (OR: 0.06, 95% CI: 0.03–0.11), and Hispanic/Latinx (OR: 0.56, 95% CI: 0.36–0.88) children had lower odds of appropriate testing compared with White and non-Hispanic/Latinx children.

Conclusions

Fewer than half of HCV-exposed children in this national sample were tested for HCV, with lower testing odds among Black, Asian/Pacific Islander, and Hispanic/Latinx children. Substantial work to increase testing and treatment and decrease disparities in testing among HCV-exposed children is needed to help reach US HCV elimination goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Healthcare DisparitiesHepatitis CChildChild, PreschoolFemaleHumansInfantInfant, NewbornMalePregnancyEthnicityHepacivirusHepatitis C AntibodiesInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousRetrospective StudiesRNA, ViralUnited StatesRacial Groups

Stichwörter der Autor:innen

HCV testinghepatitis C virusmother-to-child transmissionpediatric treatmentracial disparities

Substanzen

Hepatitis C AntibodiesRNA, Viral

Autor:innen und Institutionen

  • Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
  • Department of Pediatrics, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
  • Boston University School of Public Health, Boston, Massachusetts, USA.
  • Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA.
  • Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Rachel L Epstein, Sarah Munroe

Förderung

  • NIDA NIH HHS
  • NIAID NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • National Institute on Drug Abuse
  • National Institute of Allergy and Infectious Diseases
  • Boston University Clinical and Translational Science Institute

Zitieren

APA

Epstein, R. L., Kurnellas, A., Munroe, S., Curtis, M. R., Biondi, B., & Wachman, E. M. (2024). Racial and Ethnic Disparities in Testing of Hepatitis C Virus–Exposed Children Across the United States. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piae082

Vancouver

Epstein RL, Kurnellas A, Munroe S, Curtis MR, Biondi B, Wachman EM. Racial and Ethnic Disparities in Testing of Hepatitis C Virus–Exposed Children Across the United States. Journal of the Pediatric Infectious Diseases Society. 2024. doi:10.1093/jpids/piae082

BibTeX
@article{Epstein2024,
  author = {Epstein, Rachel L and Kurnellas, Anna and Munroe, Sarah and Curtis, Megan R and Biondi, Breanne and Wachman, Elisha M},
  title = {Racial and Ethnic Disparities in Testing of Hepatitis C Virus–Exposed Children Across the United States},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2024},
  doi = {10.1093/jpids/piae082}
}
Kostenlos starten →